NY Judge’s Ruling in Tilray Securities Class Action: Implications for Pharmaceutical and Cannabis Industries
In a noteworthy legal development, Judge Paul A. Crotty of the United States District Court for the Southern District of New York recently ruled on a motion for reconsideration in a securities class action. The case, Kasilingam et al. v. Tilray Inc., et al., No. 1:20-cv-03459, involves a pharmaceutical and cannabis company, along with certain…